Satraplatin CAS 129580-63-8

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Num­ber

129580-63-8

Name

Satraplatin

Syn­onyms

Acetic acid, com­pd. with cyclo­hexa­namine, platinum(4+) salt, hydrochlo­ride, ammo­ni­ate (2:1:1:2:1) [ACD/​Index Name] Chlorure acé­tate de platine(4+) – cyclo­hexa­namine, ammo­ni­ate (2:2:1:1:1) [French] [ACD/IUPAC Name] Platin(4+)chloridacetat -cyclo­hexa­nam­i­nam­mo­ni­at (1:2:2:1:1) [Ger­man] [ACD/IUPAC Name] Platinum(4+) chlo­ride acetate cyclo­hexa­namine ammo­ni­ate (1:2:2:1:1) [ACD/IUPAC Name] (OC-6-43)-Bis(acetato-0)ammine-dichloro(cyclohexanamine)Platinum (IV) [129580-63-8] 129580-63-8 [RN] 367265-85-8 [RN] Bisacetatoammine-dichloro(cyclohexanamine)Platinum (IV) bis-aceta­­toam­minedichloro­­cy­­clo­hexy­lamine platinum(IV) C081294 Cyclo­hexa­namine, plat­inum com­plex JM216 MFCD00871429 platinum(4+) ion cyclo­hexa­namine diac­etate amine dichlo­ride platinum(4+) ion cyclo­hexy­lamine diac­etate amine dichlo­ride Plat­inum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (OC-6-43)- Plat­inum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)- Poplat Satraplatin UNII:8D7B37T28G UNII-8D7B37T28G

Mol­e­c­u­lar Structure

SMILES

CC(=O)[O-].CC(=O)[O-].C1CCC(CC1)N.N.[Cl-].[Cl-].[Pt+4]

Std­InChI

InChI=1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+4/p-4

Std­InChIKey

CKN­P­W­BAX­EKSCRG-UHF­F­­FAOYSA-J

Mol­e­c­u­lar Formula

C10H22Cl2N2O4Pt

Mol­e­c­u­lar Weight

500.28

Prop­er­ties

Appear­ance

Light yel­low and odor­less crys­talline

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Satraplatin CAS 129580-63-8

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC,IR

Assay

98.0%~102.0%

Acid­i­ty

5.5~6.5

Relat­ed substance

If impu­ri­ty peak appears in HPLC, the sum of impu­ri­ties peaks should be not more than the area of RS main peak 2.0%

Loss on Drying

≤0.5%

Pt content（Gravimetric method）

38.7%~39.3%

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the API for treat­ment of lung and ovar­i­an can­cers

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com), and here is the cor­re­spond­ing linkhttp://​cam​ing​.com/​s​a​t​r​a​p​l​a​t​i​n​-​c​a​s​-​1​2​9​5​8​0​-​6​3​-8/